High-frequency extracellular spiking in electrically-active cancer cells

Rustamzhon Melikov,Francesco De Angelis,Rosalia Moreddu

DOI: https://doi.org/10.1101/2024.03.16.585162

2024-03-17

Abstract:Microelectrode matrices have been extensively used in the past 30 years as a reliable platform to record the extracellular activity of cells traditionally regarded to as excitable, i.e. brain cells and muscle cells. Meanwhile, fundamental biology studies on cancer cells since the 1970s reveal that they exhibit altered functionalities of ion channels, membrane potentials, metabolism, and communication mechanisms when compared to their healthy counterparts. In this work, we present for the first time the presence of extracellular voltage spikes occurring at high frequencies (0.1-3.5 kHz) in breast cancer cells, resembling the ones observed in excitable cells, and the possibility to record them with 30 µm TiN microelectrode matrices. These preliminary findings may open a new path for exploration in a variety of research fields, enabling the access to bioelectrical dynamics in cancer cells and cell networks, targeting bioelectricity as a tool in anticancer drug development and cancer diagnostics, as well as provide a market expansion for companies commercializing microelectrodes and microelectrode recording systems.

Bioengineering

What problem does this paper attempt to address?

The paper attempts to address the issue of detecting high-frequency (0.1-3.5 kHz) extracellular voltage spikes in breast cancer cells and to explore the bioelectrical characteristics of these signals and their relationship with cell behavior. Specifically, the study recorded the electrical activity of four different subtypes of triple-negative breast cancer cells using 30-micron titanium nitride microelectrode arrays. These findings reveal that breast cancer cells exhibit not only low-frequency signals but also high-frequency spike discharges similar to excitable cells.

The research further investigates the differences in electrical activity among different subtypes of breast cancer cells and validates the biological origin of these signals through pharmacological means, particularly by observing changes in electrical activity through the blockade of specific ion channels. Ultimately, the results indicate that high-frequency electrical activity may be related to the metastatic potential of the cells, laying the foundation for further research in the fields of nanotechnology, drug testing, diagnostics, and basic biology.